Edition:
United States

People: PerkinElmer Inc (PKI)

PKI on New York Consolidated

57.82USD
27 Mar 2017
Change (% chg)

$0.30 (+0.52%)
Prev Close
$57.52
Open
$57.68
Day's High
$58.37
Day's Low
$57.24
Volume
117,578
Avg. Vol
692,243
52-wk High
$58.37
52-wk Low
$45.35

Sato, Vicki 

Dr. Vicki L. Sato Ph.D., was an Independent Director of Perkinelmer Inc. Dr. Sato was appointed Professor of Management Practice at Harvard Business School in 2006. Prior to that, she had been the President of Vertex Pharmaceuticals from 2000 until her retirement from that position in 2005, and had previously served eight years as Vertex’s Chief Scientific Officer and Chair of the scientific advisory board. Prior to joining Vertex in 1992, she was with Biogen, Inc. from 1984 to 1992, most recently as Vice President of Research and a member of the scientific advisory board. Dr. Sato is also a business advisor to various enterprises in the biotechnology and pharmaceutical industries. Dr. Sato serves as an overseer of the Isabella Stewart Gardner Museum. She is currently a director of BorgWarner Inc. and Bristol-Myers Squibb Company, and during the past five years has served as a director of Galapagos NV and Alnylam Pharmaceuticals, Inc. She is the author of numerous professional publications and holds several issued or pending patents. Dr. Sato received her Bachelor, Master and Doctoral degrees from Harvard University.

Basic Compensation

Total Annual Compensation, USD 99,000
Restricted Stock Awards, USD 174,998
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 273,998

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Friel

9,522,220

Frank Wilson

2,378,770

Deborah Butters

--

James Corbett

2,445,020

Joel Goldberg

2,038,850

Prahlad Singh

1,172,880
As Of  31 Dec 2016